Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections may be an effective treatment for severe hair loss.

Some skin diseases and their treatments can negatively affect male fertility.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Lichen planus may be associated with a higher risk of metabolic syndrome.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

An 8-year-old boy had both alopecia areata and vitiligo on the same spot on his scalp, which is very rare.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.